Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
59.94
+0.91 (1.54%)
Nov 22, 2024, 4:00 PM EST - Market closed

Rhythm Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
3,6842,7171,6415021,3141,009
Upgrade
Market Cap Growth
137.11%65.56%227.08%-61.83%30.31%9.04%
Upgrade
Enterprise Value
3,6402,4191,2951761,116850
Upgrade
Last Close Price
59.9445.9729.129.9829.7322.96
Upgrade
PS Ratio
32.1735.0969.42159.06--
Upgrade
PB Ratio
20.9716.006.211.777.893.59
Upgrade
P/TBV Ratio
663.5216.696.401.797.893.59
Upgrade
EV/Sales Ratio
32.3531.2454.7955.81--
Upgrade
Debt / Equity Ratio
0.740.630.290.010.020.01
Upgrade
Asset Turnover
0.310.220.070.01--
Upgrade
Inventory Turnover
1.181.611.41---
Upgrade
Quick Ratio
3.255.278.536.819.6011.98
Upgrade
Current Ratio
3.495.588.907.1010.1012.38
Upgrade
Return on Equity (ROE)
-147.90%-85.10%-66.05%-30.89%-59.88%-53.38%
Upgrade
Return on Assets (ROA)
-46.24%-32.22%-31.45%-41.15%-34.45%-32.09%
Upgrade
Return on Capital (ROIC)
-71.39%-37.22%-35.62%-46.58%-37.59%-34.38%
Upgrade
Earnings Yield
-7.10%-6.80%-11.04%-13.88%-10.20%-13.95%
Upgrade
FCF Yield
-3.38%-5.01%-10.59%-29.19%-9.30%-12.51%
Upgrade
Buyback Yield / Dilution
-6.06%-10.65%-5.08%-12.40%-21.15%-17.48%
Upgrade
Total Shareholder Return
-6.06%-10.65%-5.08%-12.40%-21.15%-17.48%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.